×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Kala Bio Inc.. (KALA) NASDAQ

$7.83 (0.02) (-0.26%)

Market Cap: $21.14M

As of 03/28/24 09:31 AM EDT. Market closed.

(KALA)

Kala Bio Inc.. (KALA)
NASDAQ

$7.83
(0.02) (-0.26%)

Market Cap: $21.14M

As of 03/28/24 09:31 AM EDT. Market closed.

Add to Portfolio

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at ... read more

kala pharmaceuticals, inc. (kala) is a biopharmaceutical company focused on the development and commercialization of therapeutics using our proprietary nanoparticle-based mucus penetrating particles, or mpp, technology, with an initial focus on the treatment of eye diseases. for more information, please visit kala’s website at www.kalarx.com. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Mark Iwicki
Full Time Employees
111
CEO Compensation (Base)
$534,681
CEO Compensation (Total)
$3.07M
URL
Address
490 Arsenal Way, Suite 120, Massachusetts, Watertown, 02472.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
CEO
Mark Iwicki
Full Time Employees
111
CEO Compensation (Base)
$534,681
CEO Compensation (Total)
$3.07M
Address
490 Arsenal Way, Suite 120, Massachusetts, Watertown, 02472.
PRICE CHART FOR KALA BIO INC.
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$7.83
Previous Close
$7.85
Days Range
$7.70 - $7.99
52 week range
$5.10 - $19.57
Volume
9,892
Avg. Volume (30 days)
16,881
Market Cap
$21.14M
Dividend Yield
-
P/E
(2.45)
Shares Outstanding
2,693,116
Open
$7.83
Previous Close
$7.85
Days Range
$7.70 - $7.99
52 week range
$5.10 - $19.57
Volume
9,892
Avg. Volume (30 days)
16,881
Market Cap
$21.14M
Dividend Yield
-
P/E
(2.45)
Shares Outstanding
2,693,116
FINANCIAL STATEMENTS FOR KALA BIO INC.
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR KALA BIO INC.
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Trachtenberg EricSEE REMARKSJan 04, 2024 Sale$6.741,2278,27068,066Jan 05, 2024, 04:07 PM
Kharabi DariusCHIEF BUSINESS OFFICERJan 04, 2024 Sale$6.731,3859,32165,117Jan 05, 2024, 04:06 PM
Brazzell Romulus KSEE REMARKSJan 04, 2024 Sale$6.741,61710,89991,473Jan 05, 2024, 04:05 PM
Iwicki Mark TCHIEF EXECUTIVE OFFICERJan 04, 2024 Sale$6.734,53930,547286,315Jan 05, 2024, 04:04 PM
Reumuth MaryCHIEF FINANCIAL OFFICERJan 04, 2024 Sale$6.741,2278,27066,136Jan 05, 2024, 04:04 PM
Bazemore ToddSEE REMARKSJan 04, 2024 Sale$6.741,4059,47089,786Jan 05, 2024, 04:03 PM
Trachtenberg EricSEE REMARKSJan 04, 2023 Sale$28.55601,71311,495Jan 06, 2023, 08:00 PM
Reumuth MaryCHIEF FINANCIAL OFFICERJan 04, 2023 Sale$28.54601,71211,883Jan 06, 2023, 08:00 PM
Brazzell Romulus KSEE REMARKSJan 04, 2023 Sale$28.53732,08318,536Jan 06, 2023, 08:00 PM
Bazemore ToddSEE REMARKSJan 04, 2023 Sale$28.54621,76914,835Jan 06, 2023, 08:00 PM
Iwicki Mark TCHIEF EXECUTIVE OFFICERJan 04, 2023 Sale$28.541985,65145,966Jan 06, 2023, 08:00 PM
Trachtenberg EricSEE REMARKSOct 26, 2022 Sale$6.521941,2652,030Oct 28, 2022, 04:15 PM
Bazemore ToddSEE REMARKSOct 26, 2022 Sale$6.512141,3932,097Oct 28, 2022, 04:15 PM
Reumuth MaryCHIEF FINANCIAL OFFICEROct 26, 2022 Sale$6.511941,2632,418Oct 28, 2022, 04:15 PM
Brazzell Romulus KSEE REMARKSOct 26, 2022 Sale$6.512611,6995,809Oct 28, 2022, 04:15 PM
Iwicki Mark TCHIEF EXECUTIVE OFFICEROct 26, 2022 Sale$6.525613,6584,464Oct 28, 2022, 04:15 PM
Trachtenberg EricSEE REMARKSJun 27, 2022 Sale$0.372,613967111,203Jun 29, 2022, 08:12 PM
Reumuth MaryCHIEF FINANCIAL OFFICERJun 27, 2022 Sale$0.372,613967130,595Jun 29, 2022, 08:12 PM
Brazzell Romulus KSEE REMARKSJun 27, 2022 Sale$0.373,1441,163285,201Jun 29, 2022, 08:11 PM
Bazemore ToddSEE REMARKSJun 27, 2022 Sale$0.373,0921,144115,499Jun 29, 2022, 08:10 PM
Iwicki Mark TCHIEF EXECUTIVE OFFICERJun 27, 2022 Sale$0.377,9752,951251,183Jun 29, 2022, 08:09 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerMay 26, 2022 Sale$0.361,005,686365,6677,039,613May 26, 2022, 05:09 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerMay 25, 2022 Sale$0.421,434,509602,4948,045,299May 25, 2022, 05:17 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerMay 24, 2022 Sale$0.51144,80573,8519,479,808May 25, 2022, 05:17 PM
RA CAPITAL MANAGEMENT, L.P.10% OwnerMay 23, 2022 Sale$0.651,250,000812,5009,624,613May 25, 2022, 05:17 PM
Reumuth MaryCHIEF FINANCIAL OFFICERJan 04, 2022 Sale$1.302,8503,705133,208Jan 05, 2022, 08:00 PM
Brazzell Romulus KSEE REMARKSJan 04, 2022 Sale$1.303,5044,555288,345Jan 05, 2022, 08:00 PM
Bazemore ToddSEE REMARKSJan 04, 2022 Sale$1.303,4544,490118,591Jan 05, 2022, 08:00 PM
Iwicki Mark TCHIEF EXECUTIVE OFFICERJan 04, 2022 Sale$1.309,51812,373259,158Jan 05, 2022, 08:00 PM
Trachtenberg EricSEE REMARKSJan 04, 2022 Sale$1.302,8503,705113,816Jan 05, 2022, 08:00 PM
Chen HongmingCHIEF SCIENTIFIC OFFICEROct 27, 2021 Sale$1.8221,05138,313204,515Oct 28, 2021, 08:06 PM
Chen HongmingCHIEF SCIENTIFIC OFFICEROct 26, 2021 Sale$1.809,44917,008225,566Oct 28, 2021, 08:06 PM
Trachtenberg EricSEE REMARKSOct 26, 2021 Sale$1.809,44917,008116,666Oct 28, 2021, 08:05 PM
Reumuth MaryCHIEF FINANCIAL OFFICEROct 26, 2021 Sale$1.809,44917,008136,058Oct 28, 2021, 08:04 PM
Bazemore ToddCHIEF OPERATING OFFICEROct 26, 2021 Sale$1.8012,54422,579122,045Oct 28, 2021, 08:03 PM
Brazzell Romulus KCHIEF MEDICAL OFFICEROct 26, 2021 Sale$1.8012,75722,963291,849Oct 28, 2021, 08:02 PM
Iwicki Mark TCHIEF EXECUTIVE OFFICEROct 26, 2021 Sale$1.8027,59849,676268,676Oct 28, 2021, 08:01 PM
Chen HongmingCHIEF SCIENTIFIC OFFICERJun 29, 2021 Sale$5.565,54830,847235,015Jun 30, 2021, 05:30 PM
Chen HongmingCHIEF SCIENTIFIC OFFICERJun 28, 2021 Sale$5.772,45214,148240,563Jun 29, 2021, 05:26 PM
Brazzell Romulus KCHIEF MEDICAL OFFICERJun 28, 2021 Sale$5.773,03417,506300,962Jun 29, 2021, 05:26 PM
Trachtenberg EricSEE REMARKSJun 28, 2021 Sale$5.772,45214,148126,115Jun 29, 2021, 05:26 PM
Reumuth MaryCHIEF FINANCIAL OFFICERJun 28, 2021 Sale$5.772,45214,148145,507Jun 29, 2021, 05:26 PM
Bazemore ToddCHIEF OPERATING OFFICERJun 28, 2021 Sale$5.772,91116,796134,589Jun 29, 2021, 05:25 PM
Iwicki Mark TCHIEF EXECUTIVE OFFICERJun 28, 2021 Sale$5.777,58643,771296,274Jun 29, 2021, 05:25 PM
Chen HongmingChief Scientific OfficerMar 01, 2021 Option Exercise$2.309,50021,850243,015Mar 03, 2021, 12:00 AM
Chen HongmingChief Scientific OfficerFeb 25, 2021 Option Exercise$2.3047,000108,100233,515Feb 26, 2021, 05:35 PM
Bazemore ToddChief Operating OfficerJun 05, 2020 Buy$13.392272Oct 28, 2020, 08:36 PM
Bazemore ToddChief Operating OfficerOct 22, 2020 Buy$7.604030442Oct 28, 2020, 08:36 PM
Rosen Howard BDirectorAug 19, 2019 Option Exercise$0.604,8242,8724,824Jun 29, 2020, 09:54 PM
Trachtenberg EricSee RemarksJun 19, 2020 Option Exercise$5.1928,901149,99628,901Jun 22, 2020, 04:06 PM
Reumuth MaryChief Financial OfficerJun 09, 2020 Option Exercise$2.6443,477114,77148,293Jun 11, 2020, 04:58 PM
Brazzell Romulus KChief Medical OfficerApr 09, 2020 Option Exercise$2.9967,771202,377176,496Apr 13, 2020, 08:38 AM
Chen HongmingChief Scientific OfficerMar 30, 2020 Option Exercise$2.3031,00071,30086,849Apr 01, 2020, 04:43 PM
Bazemore ToddChief Operating OfficerMar 16, 2020 Buy$5.7510,00057,50010,000Mar 17, 2020, 05:46 PM
Grunberg GregoryDirectorMar 13, 2020 Buy$7.892,534,85419,999,9982,534,854Mar 16, 2020, 07:59 AM
Shah Rajeev M.DirectorMar 13, 2020 Buy$7.896,337,13549,999,99410,874,613Mar 13, 2020, 06:47 PM
RA CAPITAL MANAGEMENT, L.P.DirectorMar 13, 2020 Buy$7.896,337,13549,999,99410,874,613Mar 13, 2020, 06:45 PM
Rosen Howard BDirectorMay 30, 2019 Buy$5.425,00027,1008,240Jun 03, 2019, 10:41 AM
Grunberg GregoryDirectorOct 05, 2018 Buy$8.25606,0604,999,9952,877,006Oct 09, 2018, 04:46 PM
Shah Rajeev M.DirectorOct 03, 2018 Buy$8.252,424,24219,999,9974,537,478Oct 05, 2018, 04:34 PM
RA CAPITAL MANAGEMENT, LLCDirectorOct 03, 2018 Buy$8.252,424,24219,999,9974,537,478Oct 05, 2018, 04:33 PM
Chen HongmingChief Scientific OfficerFeb 28, 2018 Option Exercise$2.269,76922,12355,849Mar 02, 2018, 05:19 PM
ORBIMED ADVISORS LLC10% OwnerFeb 08, 2018 Buy$12.9325,000323,2503,447,840Feb 12, 2018, 04:35 PM
ORBIMED ADVISORS LLC10% OwnerFeb 02, 2018 Buy$14.7337,840557,3833,422,840Feb 06, 2018, 05:05 PM
ORBIMED ADVISORS LLC10% OwnerFeb 01, 2018 Buy$14.9922,840342,3723,385,000Feb 02, 2018, 05:45 PM
ORBIMED ADVISORS LLC10% OwnerJan 31, 2018 Buy$15.00339,4005,091,0003,362,160Feb 02, 2018, 05:45 PM
ORBIMED ADVISORS LLC10% OwnerJan 26, 2018 Buy$14.9322,760339,8072,972,760Jan 30, 2018, 03:34 PM
ORBIMED ADVISORS LLC10% OwnerJan 29, 2018 Buy$14.9950,000749,5003,022,760Jan 30, 2018, 03:34 PM
ORBIMED ADVISORS LLC10% OwnerJan 24, 2018 Buy$14.9164,637963,7382,950,000Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC10% OwnerJan 23, 2018 Buy$14.994,36365,4012,885,363Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC10% OwnerJan 22, 2018 Buy$14.9875,0001,123,5002,881,000Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC10% OwnerJan 19, 2018 Buy$14.9574,9311,120,2182,806,000Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC10% OwnerJan 12, 2018 Buy$14.5038,354556,1332,731,069Jan 24, 2018, 08:59 PM
ORBIMED ADVISORS LLC10% OwnerJan 12, 2018 Buy$15.4028,446438,0682,692,715Jan 12, 2018, 05:29 PM
ORBIMED ADVISORS LLC10% OwnerJan 11, 2018 Buy$13.6541,700569,2052,664,269Jan 12, 2018, 05:29 PM
ORBIMED ADVISORS LLC10% OwnerJan 10, 2018 Buy$12.83170,3382,185,4372,622,569Jan 12, 2018, 05:29 PM
Brazzell Romulus KChief Medical OfficerAug 11, 2017 Option Exercise$1.64108,725178,039108,725Aug 15, 2017, 04:08 PM
ORBIMED ADVISORS LLC10% OwnerJul 25, 2017 Buy$15.00319,3334,789,9952,375,279Jul 27, 2017, 07:17 PM
Longitude Capital Partners II, LLC10% OwnerJul 25, 2017 Buy$15.00215,0003,225,0002,270,946Jul 27, 2017, 05:23 PM
RA CAPITAL MANAGEMENT, LLCDirectorJul 25, 2017 Buy$15.00533,3337,999,9952,113,236Jul 26, 2017, 04:44 PM
Grunberg GregoryDirectorJul 25, 2017 Buy$15.00215,0003,225,0002,270,946Jul 26, 2017, 04:31 PM
Shah Rajeev M.DirectorJul 25, 2017 Buy$15.00533,3337,999,9952,113,236Jul 26, 2017, 04:31 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 20, 2017 Buy$15.00215,0003,225,000763,755Jul 21, 2017, 05:54 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 20, 2017 Buy$15.00215,0003,225,000763,755Jul 21, 2017, 03:58 PM
CDK ASSOCIATES, L.L.C.10% OwnerJul 20, 2017 Buy$15.00215,0003,225,000215,000Jul 20, 2017, 06:07 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Trachtenberg EricSEE REMARKS01/04/20248,270
Kharabi DariusCHIEF BUSINESS OFFICER01/04/20249,321
Brazzell Romulus KSEE REMARKS01/04/202410,899
Iwicki Mark TCHIEF EXECUTIVE OFFICER01/04/202430,547
Reumuth MaryCHIEF FINANCIAL OFFICER01/04/20248,270
Bazemore ToddSEE REMARKS01/04/20249,470
Trachtenberg EricSEE REMARKS01/04/20231,713
Reumuth MaryCHIEF FINANCIAL OFFICER01/04/20231,712
Brazzell Romulus KSEE REMARKS01/04/20232,083
Bazemore ToddSEE REMARKS01/04/20231,769
Iwicki Mark TCHIEF EXECUTIVE OFFICER01/04/20235,651
Trachtenberg EricSEE REMARKS10/26/20221,265
Bazemore ToddSEE REMARKS10/26/20221,393
Reumuth MaryCHIEF FINANCIAL OFFICER10/26/20221,263
Brazzell Romulus KSEE REMARKS10/26/20221,699
Iwicki Mark TCHIEF EXECUTIVE OFFICER10/26/20223,658
Trachtenberg EricSEE REMARKS06/27/2022967
Reumuth MaryCHIEF FINANCIAL OFFICER06/27/2022967
Brazzell Romulus KSEE REMARKS06/27/20221,163
Bazemore ToddSEE REMARKS06/27/20221,144
Iwicki Mark TCHIEF EXECUTIVE OFFICER06/27/20222,951
RA CAPITAL MANAGEMENT, L.P.10% Owner05/26/2022365,667
RA CAPITAL MANAGEMENT, L.P.10% Owner05/25/2022602,494
RA CAPITAL MANAGEMENT, L.P.10% Owner05/24/202273,851
RA CAPITAL MANAGEMENT, L.P.10% Owner05/23/2022812,500
Reumuth MaryCHIEF FINANCIAL OFFICER01/04/20223,705
Brazzell Romulus KSEE REMARKS01/04/20224,555
Bazemore ToddSEE REMARKS01/04/20224,490
Iwicki Mark TCHIEF EXECUTIVE OFFICER01/04/202212,373
Trachtenberg EricSEE REMARKS01/04/20223,705
Chen HongmingCHIEF SCIENTIFIC OFFICER10/27/202138,313
Chen HongmingCHIEF SCIENTIFIC OFFICER10/26/202117,008
Trachtenberg EricSEE REMARKS10/26/202117,008
Reumuth MaryCHIEF FINANCIAL OFFICER10/26/202117,008
Bazemore ToddCHIEF OPERATING OFFICER10/26/202122,579
Brazzell Romulus KCHIEF MEDICAL OFFICER10/26/202122,963
Iwicki Mark TCHIEF EXECUTIVE OFFICER10/26/202149,676
Chen HongmingCHIEF SCIENTIFIC OFFICER06/29/202130,847
Chen HongmingCHIEF SCIENTIFIC OFFICER06/28/202114,148
Brazzell Romulus KCHIEF MEDICAL OFFICER06/28/202117,506
Trachtenberg EricSEE REMARKS06/28/202114,148
Reumuth MaryCHIEF FINANCIAL OFFICER06/28/202114,148
Bazemore ToddCHIEF OPERATING OFFICER06/28/202116,796
Iwicki Mark TCHIEF EXECUTIVE OFFICER06/28/202143,771
Chen HongmingChief Scientific Officer03/01/202121,850
Chen HongmingChief Scientific Officer02/25/2021108,100
Bazemore ToddChief Operating Officer06/05/202027
Bazemore ToddChief Operating Officer10/22/2020304
Rosen Howard BDirector08/19/20192,872
Trachtenberg EricSee Remarks06/19/2020149,996
Reumuth MaryChief Financial Officer06/09/2020114,771
Brazzell Romulus KChief Medical Officer04/09/2020202,377
Chen HongmingChief Scientific Officer03/30/202071,300
Bazemore ToddChief Operating Officer03/16/202057,500
Grunberg GregoryDirector03/13/202019,999,998
Shah Rajeev M.Director03/13/202049,999,994
RA CAPITAL MANAGEMENT, L.P.Director03/13/202049,999,994
Rosen Howard BDirector05/30/201927,100
Grunberg GregoryDirector10/05/20184,999,995
Shah Rajeev M.Director10/03/201819,999,997
RA CAPITAL MANAGEMENT, LLCDirector10/03/201819,999,997
Chen HongmingChief Scientific Officer02/28/201822,123
ORBIMED ADVISORS LLC10% Owner02/08/2018323,250
ORBIMED ADVISORS LLC10% Owner02/02/2018557,383
ORBIMED ADVISORS LLC10% Owner02/01/2018342,372
ORBIMED ADVISORS LLC10% Owner01/31/20185,091,000
ORBIMED ADVISORS LLC10% Owner01/26/2018339,807
ORBIMED ADVISORS LLC10% Owner01/29/2018749,500
ORBIMED ADVISORS LLC10% Owner01/24/2018963,738
ORBIMED ADVISORS LLC10% Owner01/23/201865,401
ORBIMED ADVISORS LLC10% Owner01/22/20181,123,500
ORBIMED ADVISORS LLC10% Owner01/19/20181,120,218
ORBIMED ADVISORS LLC10% Owner01/12/2018556,133
ORBIMED ADVISORS LLC10% Owner01/12/2018438,068
ORBIMED ADVISORS LLC10% Owner01/11/2018569,205
ORBIMED ADVISORS LLC10% Owner01/10/20182,185,437
Brazzell Romulus KChief Medical Officer08/11/2017178,039
ORBIMED ADVISORS LLC10% Owner07/25/20174,789,995
Longitude Capital Partners II, LLC10% Owner07/25/20173,225,000
RA CAPITAL MANAGEMENT, LLCDirector07/25/20177,999,995
Grunberg GregoryDirector07/25/20173,225,000
Shah Rajeev M.Director07/25/20177,999,995
CDK ASSOCIATES, L.L.C.10% Owner07/20/20173,225,000
CDK ASSOCIATES, L.L.C.10% Owner07/20/20173,225,000
CDK ASSOCIATES, L.L.C.10% Owner07/20/20173,225,000
Load More Insider Transactions
FUNDS WITH A POSITION IN KALA BIO INC.
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP266,6130.02%No changeOther
BLACKROCK INC.27,3210%4.68%Other
GEODE CAPITAL MANAGEMENT, LLC18,4650.00001%No changeOther
RENAISSANCE TECHNOLOGIES LLC14,1000.00015%NewOther
CHANGE IN SHARES OUTSTANDING FOR KALA BIO INC.
STOCK BUYBACKS FOR KALA BIO INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
09/30/2023
06/30/2023
6.80%
1Q
09/30/2023
03/31/2023
23.25%
2Q
09/30/2023
06/30/2022
71.63%
5Q
09/30/2023
03/31/2022
71.71%
6Q
09/30/2023
12/31/2021
81.81%
7Q
Load More

Period of Report: 09/30/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
06/30/2023
6.80%
1Q
03/31/2023
23.25%
2Q
06/30/2022
71.63%
5Q
03/31/2022
71.71%
6Q
12/31/2021
81.81%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR KALA BIO INC.
LOADING...